Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aringer, M
Right arrow Articles by Smolen, J S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aringer, M
Right arrow Articles by Smolen, J S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 14, No. 1, 13-18 (2005)
DOI: 10.1191/0961203305lu2053oa

Cytokine expression in lupus kidneys

M Aringer

Department of Rheumatology, Medical University of Vienna, Vienna, Austria

J S Smolen

Department of Rheumatology, Medical University of Vienna, Vienna, Austria, martin.aringer{at}meduniwien.ac.at

Although far from complete, the picture of cytokines present in systemic lupus erythematosus (SLE) glomerulonephritis is already complex. Proinflammatory cytokines, such as TNF, IL-6, IL-1, and IL-18 are upregulated, as are both Th1 and Th2 cytokines, with different implications. In many instances, the local effects may be different from the systemic immunoregulatory ones. For some proinflammatory cytokines, and TNF in particular, the local proinflammatory ones may be more relevant to the disease. This may help solve discrepancies between different murine models of the disease and provide a better rationale for targeting certain cytokines in human SLE.

Key Words: fibrosis • glomerulonephritis • inflammation • lupus • renal cytokines


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
T.-C. Hsu, S.-Y. Chiang, C.-Y. Huang, G. J. Tsay, C.-W. Yang, C.-N. Huang, and B.-S. Tzang
Beneficial Effects of Treatment with Transglutaminase Inhibitor Cystamine on Macrophage Response in NZB/W F1 Mice
Experimental Biology and Medicine, February 1, 2007; 232(2): 195 - 203.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Ryan and G. R. McLemore Jr.
Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R736 - R742.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
M DeBandt
Lessons for lupus from tumour necrosis factor blockade
Lupus, November 1, 2006; 15(11): 762 - 767.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. V. Navarra
Immune therapy of lupus: what is on the horizon?
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 579 - 581.
[Full Text] [PDF]